TP53TG1

gene
On this page

Also known as H_RG012D21.9LINC00096TP53LC12

Summary

TP53TG1 (TP53 target 1, HGNC:17026) is a long non-coding RNA gene on chromosome 7q21.12.

At a glance

  • Gene type: non-coding (lncRNA) — no protein product; not a drug target. Variant/disease associations are omitted (they would be positional, from an overlapping protein-coding gene).

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:17026
Approved symbolTP53TG1
NameTP53 target 1
Location7q21.12
Locus typeRNA, long non-coding
StatusApproved
AliasesH_RG012D21.9, LINC00096, TP53LC12
Ensembl geneENSG00000182165
Ensembl biotypelncRNA
OMIM616403
Entrez11257
RNAcentralURS000075D314 — lncRNA, 751 nt, 1 organism(s)

Gene structure

Transcript identifiers

Ensembl transcripts: 63 — 63 lncRNA

ENST00000359941, ENST00000416560, ENST00000421293, ENST00000432193, ENST00000542586, ENST00000610086, ENST00000616845, ENST00000653182, ENST00000654969, ENST00000661943, ENST00000685527, ENST00000685636, ENST00000685707, ENST00000685722, ENST00000686297, ENST00000686728, ENST00000687819, ENST00000688353, ENST00000689667, ENST00000690980, ENST00000701419, ENST00000702094, ENST00000702749, ENST00000766307, ENST00000766308, ENST00000766309, ENST00000766310, ENST00000766311, ENST00000766312, ENST00000766313, ENST00000766314, ENST00000766315, ENST00000766316, ENST00000766317, ENST00000766318, ENST00000766319, ENST00000766320, ENST00000766321, ENST00000766322, ENST00000766323, ENST00000766324, ENST00000766325, ENST00000766326, ENST00000766327, ENST00000766328, ENST00000766329, ENST00000766330, ENST00000766331, ENST00000766332, ENST00000766333, ENST00000766334, ENST00000766335, ENST00000766336, ENST00000766337, ENST00000766338, ENST00000766339, ENST00000766340, ENST00000766341, ENST00000766342, ENST00000766343, ENST00000766344, ENST00000766345, ENST00000766346

RefSeq mRNA: 0 — MANE Select: None

Canonical transcript exons

ENST00000359941 — 4 exons

ExonStartEnd
ENSE000013025598734152387341684
ENSE000038564418732993587330094
ENSE000041249548734504387345540
ENSE000041249688732511587325444

Expression profiles

Bgee: expression breadth ubiquitous, 283 present calls, max score 93.59.

FANTOM5 (CAGE): breadth ubiquitous, TPM avg 16.9039 / max 175.2569, expressed in 1760 samples.

FANTOM5 promoters (5 alternative TSS)

Promoter IDTPM avgSamples expressed
8471814.85551755
847171.3685671
847150.3671175
847160.205994
847140.106828

Top tissues by expression

293 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
mucosa of transverse colonUBERON:000499193.59gold quality
olfactory segment of nasal mucosaUBERON:000538693.16gold quality
right lobe of liverUBERON:000111491.08gold quality
right uterine tubeUBERON:000130290.19gold quality
transverse colonUBERON:000115790.13gold quality
hindlimb stylopod muscleUBERON:000425289.90gold quality
right adrenal glandUBERON:000123389.87gold quality
right adrenal gland cortexUBERON:003582789.83gold quality
skin of abdomenUBERON:000141689.40gold quality
lower esophagusUBERON:001347389.17gold quality
lower esophagus muscularis layerUBERON:003583389.16gold quality
C1 segment of cervical spinal cordUBERON:000646989.08gold quality
epithelium of bronchusUBERON:000203188.96gold quality
skin of legUBERON:000151188.91gold quality
left adrenal gland cortexUBERON:003582588.83gold quality
left adrenal glandUBERON:000123488.77gold quality
left coronary arteryUBERON:000162688.74gold quality
esophagogastric junction muscularis propriaUBERON:003584188.64gold quality
bronchusUBERON:000218588.59gold quality
pancreatic ductal cellCL:000207988.56gold quality
bronchial epithelial cellCL:000232888.44gold quality
muscle layer of sigmoid colonUBERON:003580588.40gold quality
lower esophagus mucosaUBERON:003583488.40gold quality
esophagusUBERON:000104388.31gold quality
popliteal arteryUBERON:000225088.25gold quality
tibial arteryUBERON:000761088.23gold quality
descending thoracic aortaUBERON:000234588.22gold quality
adrenal cortexUBERON:000123588.20gold quality
ascending aortaUBERON:000149688.19gold quality
thoracic aortaUBERON:000151588.18gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 1.

ExperimentMarker?Max mean expression
E-ANND-3no0.00

Regulation

Is transcription factor: no

Literature-anchored findings (GeneRIF, showing 9)

  • From our analysis, variants in the genes ABCB4, TP53AIP1, ARHGAP32 and TMEM88B were identified linked to the alexithymia phenotype. (PMID:25882097)
  • Study reports that TP53TG1 is an lncRNA that is critical for the correct response of p53 to DNA damage. The cancer growth suppressor features of TP53TG1 are linked to its ability to block the tumorigenic activity of the RNA binding protein YBX1. The DNA methylation-associated silencing of TP53TG1 produces aggressive tumors that are resistant to cellular death when DNAdamaging agents and small targeted molecules are used. (PMID:27821766)
  • data showed that TP53TG1 under glucose deprivation may promote cell proliferation and migration by influencing the expression of glucose metabolism related genes in glioma. (PMID:28569381)
  • TP53TG1 could directly bind to miR-96 and effectively function as a sponge for miR-96, antagonizing the functions of miR-96 and leading to derepression of KRAS, which is a core oncogene in the initiation and maintenance of pancreatic ductal adenocarcinoma (PDAC). TP53TG1 contributes to the growth and progression of PDAC by acting as a competing endogenous RNA to competitively bind to miR-96 and regulate KRAS expression. (PMID:31325400)
  • Survival analysis for long noncoding RNAs identifies TP53TG1 as an antioncogenic target for the breast cancer. (PMID:32020607)
  • Long Noncoding RNA TP53TG1 Contributes to Radioresistance of Glioma Cells Via miR-524-5p/RAB5A Axis. (PMID:32762546)
  • Long non-coding RNA tumor protein 53 target gene 1 promotes cervical cancer development via regulating microRNA-33a-5p to target forkhead box K2. (PMID:35090377)
  • Comprehensive analysis of DRAIC and TP53TG1 in breast cancer luminal subtypes through the construction of lncRNAs regulatory model. (PMID:35871431)
  • m6A modification-mediated lncRNA TP53TG1 inhibits gastric cancer progression by regulating CIP2A stability. (PMID:36114757)

Cross-species orthologs

0 orthologs

Protein

Non-coding RNA — no protein product; not a drug target.

Function

No curated pathway, Gene-Ontology, or interaction data.

Disease & clinical

No curated disease, variant, or cancer-driver associations.

Drugs & pharmacology

No drug or pharmacology data — not an established drug target.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.